相似文献
1
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
Br J Clin Pharmacol. 1976 Oct;3(5):849-55. doi: 10.1111/j.1365-2125.1976.tb00637.x.
2
Pharmacological basis for antihypertensive effects of intravenous labetalol.
Br Heart J. 1977 Jan;39(1):99-106. doi: 10.1136/hrt.39.1.99.
3
Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
Br J Clin Pharmacol. 1984 May;17(5):565-72. doi: 10.1111/j.1365-2125.1984.tb02391.x.
4
The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
Clin Exp Hypertens (1978). 1979;1(5):597-611. doi: 10.3109/10641967909068627.
5
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4.
6
The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Br J Pharmacol. 1991 Dec;104(4):823-8. doi: 10.1111/j.1476-5381.1991.tb12513.x.
7
Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Jpn J Pharmacol. 1985 May;38(1):31-41. doi: 10.1254/jjp.38.31.
8
Pharmacological effects of labetalol in man.
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3.
9
Alpha-adrenoceptor blockade by labetalol during long-term dosing.
Clin Pharmacol Ther. 1983 Mar;33(3):278-82. doi: 10.1038/clpt.1983.33.
10
Concurrent antagonism of isoproterenol and norepinephrine after labetalol.
Clin Pharmacol Ther. 1978 Mar;23(3):253-8. doi: 10.1002/cpt1978233253.
引用本文的文献
1
Retrospective evaluation of labetalol as antihypertensive agent in dogs.
BMC Vet Res. 2020 Jul 24;16(1):256. doi: 10.1186/s12917-020-02475-4.
2
Treatment Strategies for Paradoxical Hypertension Following Surgical Correction of Coarctation of the Aorta in Children.
World J Pediatr Congenit Heart Surg. 2017 May;8(3):321-331. doi: 10.1177/2150135117690104.
3
Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis.
J Am Heart Assoc. 2017 May 17;6(5):e005526. doi: 10.1161/JAHA.117.005526.
4
Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.
Cardiovasc Drugs Ther. 1996 Mar;10(1):23-30. doi: 10.1007/BF00051127.
5
Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.
Eur J Clin Pharmacol. 1980 Jan;17(1):5-11. doi: 10.1007/BF00561670.
6
Elimination kinetics of labetalol in severe renal failure.
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):81S-86S. doi: 10.1111/j.1365-2125.1982.tb01893.x.
7
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):115S-122S. doi: 10.1111/j.1365-2125.1982.tb01899.x.
8
Changes in heart rate and forearm blood flow following intravenous boluses of isoprenaline in the presence of practolol and propranolol.
Br J Clin Pharmacol. 1983 Jan;15(1):37-40. doi: 10.1111/j.1365-2125.1983.tb01460.x.
9
Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Klin Wochenschr. 1983 Jul 1;61(13):661-7. doi: 10.1007/BF01487583.
10
Pharmacology of combined alpha-beta-blockade. I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
本文引用的文献
1
A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.
Lancet. 1964 Feb 8;1(7328):296-300. doi: 10.1016/s0140-6736(64)92408-0.
2
Circulatory effects of sympathomimetic amines.
Am Heart J. 1962 Jan;63:119-35. doi: 10.1016/0002-8703(62)90230-2.
3
Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide).
Lancet. 1962 Aug 18;2(7251):314-6. doi: 10.1016/s0140-6736(62)90104-6.
4
Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.
Br J Pharmacol. 1968 Sep;34(1):127-40. doi: 10.1111/j.1476-5381.1968.tb07956.x.
5
Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.
Br Heart J. 1974 Jun;36(6):588-96. doi: 10.1136/hrt.36.6.588.
6
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
Br J Pharmacol. 1972 Aug;45(4):660-75. doi: 10.1111/j.1476-5381.1972.tb08125.x.
7
Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man.
Clin Sci. 1971 Apr;40(4):18P-19P. doi: 10.1042/cs040018pa.
8
Adrenoceptors and adenyl cyclase in gills.
Br J Pharmacol. 1973 Sep;49(1):134-7. doi: 10.1111/j.1476-5381.1973.tb08277.x.
9
Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A.
Br J Pharmacol. 1972 Feb;44(2):286-93. doi: 10.1111/j.1476-5381.1972.tb07265.x.
10
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
Clin Sci Mol Med Suppl. 1975 Jun;2:97s-100s. doi: 10.1042/cs048097s.
Zotero 插件